A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

NCT00000855 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)